Showing results (81-90 of 660) with videos related to

Sort By:
Pageof 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancerIan Chau, Gina Brown, David Cunningham, et al.
Clinical Colorectal Cancer|August 28, 2019
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UKShelize Khakoo, Ian Chau, Ian Pedley, et al.
BMC Hematology|August 22, 2018
Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patientsAndrea Kühnl, David Cunningham, Margaret Hutka, et al.
World Journal of Gastrointestinal Oncology|August 7, 2018
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancerHazel Lote, Nicola Valeri, Ian Chau
Expert Review of Hematology|November 20, 2015
Beginning of a novel frontier: T-cell-directed immune manipulation in lymphomasBenjamin Kasenda, Andrea Kühnl, Ian Chau
Cancer Treatment Reviews|September 29, 2015
PD-1 and PD-L1 blockade in gastrointestinal malignanciesHazel Lote, Catherine Cafferkey, Ian Chau
Therapeutic Advances in Gastroenterology|November 12, 2015
Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinomaKate Young, Elizabeth Smyth, Ian Chau
Current Oncology (Toronto, Ont.)|November 26, 2025
New Horizons with Growth Differentiation Factor 15 in Oncology: From Cancer Cachexia and Tumour Immunity to Novel Therapeutic StrategiesKeiji Sugiyama, Naureen Starling, Ian Chau
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 3, 2004
The vital role of education and information in patients receiving capecitabine (Xeloda)Ian Chau, Sally Legge, Pierre Fumoleau
Clinical Colorectal Cancer|November 9, 2018
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center ExperienceKhurum Khan, Jayant K Rane, David Cunningham, et al.
Pageof 66